Soaring obesity1 in US children is creating a dramatic increase in the number taking medicines for type-II diabetes2 and those with diabetes-related conditions, according to a Financial Times analysis of prescription3 data.
这项剖析报告由美国最大的药品福利管理服务商Medco为英国《金融时报》提供。该剖析发现,2001至2005年间,用治疗二型糖尿病药物的儿童数目增长逾一倍。 The analysis, for the FT by Medco, the largest US drug benefits manager, found the number of children taking medicine for type-II diabetes more than doubled between 2001 and 2005.
除此之外,还发目前用治疗二型糖尿病药物的儿童中,有非常大比率的人还用其它药物,这类药物用于治疗高血压、高胆固醇、哮喘和关节疼痛等一般与肥胖和糖尿病有关的紧急成人慢成人两性疾病。
In addition, an alarming percentage of children taking type-II diabetes drugs were found to be taking drugs for serious adult-like chronic4 conditions often related to obesity and diabetes such as hypertension, high cholesterol5, asthma6 and joint7 pain.